Chenlan’s new series of marine active peptides industrialization and functional development scientific and technological achievements evaluation meeting was held in Beijing
By: Date: 2021-04-08 Categories: industrynews Tags: ,
   On April 2, the”New Series of Marine Active Peptides Industrialization and Functional Development” scientific and technological achievements evaluation meeting jointly organized by China High-tech Industrialization Research Association and Chenlan Biotechnology kicked off in Beijing.
Chenlan’s new series of marine active peptides industrialization and functional development scientific and technological achievements evaluation meeting was held in Beijingimage
   This scientific research achievement evaluation meeting specially invites Pan Xuan, deputy director of the Science and Technology Management Office of the Chinese Academy of Medical Sciences, Professor He Lan, Director of the Chemistry Department of China Food and Drug Control Institute, Professor Fan Louzhen, School of Chemistry, Beijing Normal University, National Health and Health Xu Jiao, Director of the Nutrition Division of the Food Department of the Ministry of Science and Technology, Li Linxi, former chief engineer of the Torch Center of the Ministry of Science and Technology, Professor Liu Xinqi from the School of Food Science and Technology, Beijing Technology and Business University, Zhang Heqiu, Director of the Biodiagnosis Research Office of the Institute of Basic Medicine, Academy of Military Medical Sciences, and related experts and scholars in the field of health Qi Get together to conduct scientific research evaluations on a number of innovative marine active peptides, and exchanges on academic topics such as their functional development.
  In the report of scientific research results of the project, Cao Tingfeng, the representative of Chenlan Enterprise, reported on the industrialization and functional development of clam peptides and sea cucumber peptides.
Chenlan’s new series of marine active peptides industrialization and functional development scientific and technological achievements evaluation meeting was held in Beijingimage(1)
  Clam peptide industrialization and functional development
   Two major projects carried out by Chenlan Biology have achieved a number of innovative results. As the first antihypertensive peptide product developed by using compound enzyme directed enzymatic hydrolysis technology, the project has innovative advantages such as high product yield, mild and easy-to-control production conditions, low production cost, and high safety of enzymatic hydrolysis products; the project Established a clam peptide product enterprise standard, using this standard to control the difference in functional indicators between clam peptide production batches, and solve the problem of stable functions of each batch of products; in addition, the company developed a series of special separation and purification equipment through optimization of process parameters Established a large-scale production process for clam peptides with fast production time, and has obtained the first clam peptide production license in the international active peptide industry.
  Sea cucumber peptide industrialization and functional development
   As the first Icelandic sea cucumber peptide produced by molecular weight-directed enzymatic hydrolysis technology, this product solves the difficulty of enriching the low molecular weight peptides of sea cucumber peptide products. For the first time, Chenlan Biological uses enzymatic hydrolysis-carbon fiber-membrane coupling technology to separate and purify sea cucumber peptide functional peptides; secondly, by evaluating the biological activity function of sea cucumber peptide series, the company has established the first sea cucumber peptide functional database in the industry. Product application development provides scientific basis to promote the rapid development of sea cucumber peptides in the fields of functional foods and dietary supplements.
Chenlan’s new series of marine active peptides industrialization and functional development scientific and technological achievements evaluation meeting was held in Beijingimage(2)
  Tested by SGS Standard Technical Service (Qingdao) Co., Ltd. (a third-party authoritative organization), the scientific research results of the two projects are in compliance with corporate standards. After Nanjing Boschxin Biotechnology Co., Ltd. and Kilton Biotechnology (Shanghai) Co., Ltd. conducted functional evaluation of clam peptide in SHR hypertensive rats, animal experiments showed that clam peptide has significant biological activities such as regulating blood pressure. The biological activity of sea cucumber peptides has been evaluated by Qingdao Marine Biomedical Research Institute. Experiments show that sea cucumber peptides have biological activities such as enhancing immunity, alleviating fatigue, and transdermal absorption.
   Two products have applied for a number of patents after they went on the market, and they have been published in authoritative journals in the international health field. At the same time, the products have been unanimously recognized and praised by many domestic and foreign companies such as Shanghai Laique Biology and Bio Science Marketing.
   During the meeting, the expert group reviewed the evaluation materials, listened to reports, and after rigorous inquiries and full discussions, they believed that the evaluation materials were complete and met the evaluation requirements. The expert group agreed that the technology of the project has reached the international advanced level, the social benefits are significant, and the application prospects are broad. The experts at the meeting agreed that the”Industrialization and Functional Development of New Series of Marine Active Peptides” passed the evaluation of scientific and technological achievements.
Chenlan’s new series of marine active peptides industrialization and functional development scientific and technological achievements evaluation meeting was held in Beijingimage(3)
   After the project evaluation, Zou Shengcan, chairman of the Marine Active Substances Nutrition and Health Professional Committee of China Nutrition and Health Food Association and chairman of Chenlan Biological, said that with the unique characteristics and functional advantages of marine active peptides, it will be the future diet An indispensable main force in the nutritional supplement industry. The company will continue to strengthen the research and development and market development of new serialized marine active peptides, and make efforts and contributions to promote the industrialization of innovative marine raw materials.
Chenlan’s new series of marine active peptides industrialization and functional development scientific and technological achievements evaluation meeting was held in Beijingimage(4)
Chenlan’s new series of marine active peptides industrialization and functional development scientific and technological achievements evaluation meeting was held in Beijingimage(5)
Follow Chenlan
Focus on health